2020
DOI: 10.1016/j.humpath.2020.04.001
|View full text |Cite
|
Sign up to set email alerts
|

CD10 and CD34 as markers in vascular malformations with PIK3CA and TEK mutations

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 32 publications
(37 reference statements)
0
1
0
Order By: Relevance
“…A mutation in the PIK3Ca/mTOR pathway is more often involved in various VMs. CD10 and CD34 are cellular markers that may play a role in mesenchymal differentiation and proliferation [15]. The first treatment to inhibit this pathway with sirolimus indicated that molecular treatment can be effective against VMs.…”
Section: Discussionmentioning
confidence: 99%
“…A mutation in the PIK3Ca/mTOR pathway is more often involved in various VMs. CD10 and CD34 are cellular markers that may play a role in mesenchymal differentiation and proliferation [15]. The first treatment to inhibit this pathway with sirolimus indicated that molecular treatment can be effective against VMs.…”
Section: Discussionmentioning
confidence: 99%